N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|9|6|746-758

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.9, Iss.6, 2012-07, pp. : 746-758

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N-Methyl-D-Aspartate Receptors Mediate Excitotoxicity in Amyloid Beta-Induced Synaptic Pathology of Alzheimer’s Disease

By  

Neuroembryology and Aging, Vol. 5, Iss. 4, 2009-01 ,pp. : 134-143

Karger

Access to resources Recommend Favorite

Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls

By Burton Emma J.  

Brain, Vol. 127, Iss. 4, 2004-04 ,pp. : 791-800

Oxford University Press

Access to resources Recommend Favorite

Natural Antioxidants Protect Neurons in Alzheimer’s Disease and Parkinson’s Disease

By Zhao Baolu  

Neurochemical Research, Vol. 34, Iss. 4, 2009-04 ,pp. : 630-638

Springer Publishing Company

Access to resources Recommend Favorite

Different mechanisms of corpus callosum atrophy in Alzheimer’s disease and vascular dementia

By Tomimoto Hidekazu   Lin Jin-Xi   Matsuo Akinori   Ihara Masafumi   Ohtani Ryo   Shibata Masunari   Miki Yukio   Shibasaki Hiroshi  

Journal of Neurology, Vol. 251, Iss. 4, 2004-04 ,pp. : 398-406

Springer Publishing Company

Access to resources Recommend Favorite

The Vascular Component of Alzheimer’s Disease

By  

Current Neurovascular Research, Vol. 11, Iss. 2, 2014-05 ,pp. : 168-176

Bentham Science Publishers

Access to resources Recommend Favorite